DocumentCode
1526188
Title
Computing in drug discovery: the design phase
Author
Lunney, Elizabeth A.
Author_Institution
Pfizer Global Res. & Dev., San Diego, CA, USA
Volume
3
Issue
5
fYear
2001
Firstpage
105
Lastpage
108
Abstract
Drug discovery is an extended process that can take as many as 15 years from the first compound synthesis in the laboratory until the therapeutic agent, or drug, is brought to market. Reducing the research timeline in the discovery stage is a key priority for pharmaceutical companies worldwide, and through the application and collaboration of current, advanced technologies, the industry is poised to achieve that goal. This article highlights computational chemistry, a technology that can play an important role in expediting the drug design phase
Keywords
biology computing; chemistry computing; pharmaceutical industry; computational chemistry; design phase; drug design; drug discovery; laboratory; pharmaceutical companies; Biological system modeling; Biology computing; Collaboration; Crystallography; Drugs; Hydrogen; Laboratories; Nuclear magnetic resonance; Proteins; Spectroscopy;
fLanguage
English
Journal_Title
Computing in Science & Engineering
Publisher
ieee
ISSN
1521-9615
Type
jour
DOI
10.1109/5992.947114
Filename
947114
Link To Document